127 related articles for article (PubMed ID: 16091370)
1. The binding site in {beta}2-glycoprotein I for ApoER2' on platelets is located in domain V.
van Lummel M; Pennings MT; Derksen RH; Urbanus RT; Lutters BC; Kaldenhoven N; de Groot PG
J Biol Chem; 2005 Nov; 280(44):36729-36. PubMed ID: 16091370
[TBL] [Abstract][Full Text] [Related]
2. Platelet activation by dimeric beta2-glycoprotein I requires signaling via both glycoprotein Ibalpha and apolipoprotein E receptor 2'.
Urbanus RT; Pennings MT; Derksen RH; de Groot PG
J Thromb Haemost; 2008 Aug; 6(8):1405-12. PubMed ID: 18485085
[TBL] [Abstract][Full Text] [Related]
3. Platelets express three different splice variants of ApoER2 that are all involved in signaling.
Pennings MT; Derksen RH; Urbanus RT; Tekelenburg WL; Hemrika W; de Groot PG
J Thromb Haemost; 2007 Jul; 5(7):1538-44. PubMed ID: 17470198
[TBL] [Abstract][Full Text] [Related]
4. Platelet adhesion to dimeric beta-glycoprotein I under conditions of flow is mediated by at least two receptors: glycoprotein Ibalpha and apolipoprotein E receptor 2'.
Pennings MT; Derksen RH; van Lummel M; Adelmeijer J; VanHoorelbeke K; Urbanus RT; Lisman T; de Groot PG
J Thromb Haemost; 2007 Feb; 5(2):369-77. PubMed ID: 17096706
[TBL] [Abstract][Full Text] [Related]
5. Dimers of beta 2-glycoprotein I increase platelet deposition to collagen via interaction with phospholipids and the apolipoprotein E receptor 2'.
Lutters BC; Derksen RH; Tekelenburg WL; Lenting PJ; Arnout J; de Groot PG
J Biol Chem; 2003 Sep; 278(36):33831-8. PubMed ID: 12807892
[TBL] [Abstract][Full Text] [Related]
6. Interaction of beta2-glycoprotein I with members of the low density lipoprotein receptor family.
Pennings MT; van Lummel M; Derksen RH; Urbanus RT; Romijn RA; Lenting PJ; de Groot PG
J Thromb Haemost; 2006 Aug; 4(8):1680-90. PubMed ID: 16879209
[TBL] [Abstract][Full Text] [Related]
7. Binding of low density lipoprotein to platelet apolipoprotein E receptor 2' results in phosphorylation of p38MAPK.
Korporaal SJ; Relou IA; van Eck M; Strasser V; Bezemer M; Gorter G; van Berkel TJ; Nimpf J; Akkerman JW; Lenting PJ
J Biol Chem; 2004 Dec; 279(50):52526-34. PubMed ID: 15459198
[TBL] [Abstract][Full Text] [Related]
8. Dimers of beta 2-glycoprotein I mimic the in vitro effects of beta 2-glycoprotein I-anti-beta 2-glycoprotein I antibody complexes.
Lutters BC; Meijers JC; Derksen RH; Arnout J; de Groot PG
J Biol Chem; 2001 Feb; 276(5):3060-7. PubMed ID: 11053420
[TBL] [Abstract][Full Text] [Related]
9. Protein C supports platelet binding and activation under flow: role of glycoprotein Ib and apolipoprotein E receptor 2.
White TC; Berny MA; Tucker EI; Urbanus RT; de Groot PG; Fernández JA; Griffin JH; Gruber A; McCarty OJ
J Thromb Haemost; 2008 Jun; 6(6):995-1002. PubMed ID: 18489431
[TBL] [Abstract][Full Text] [Related]
10. Anti-β2 glycoprotein I antibodies in complex with β2 glycoprotein I induce platelet activation via two receptors: apolipoprotein E receptor 2' and glycoprotein I bα.
Zhang W; Gao F; Lu D; Sun N; Yin X; Jin M; Liu Y
Front Med; 2016 Mar; 10(1):76-84. PubMed ID: 26620053
[TBL] [Abstract][Full Text] [Related]
11. Identification of coagulation factor XI as a ligand for platelet apolipoprotein E receptor 2 (ApoER2).
White-Adams TC; Berny MA; Tucker EI; Gertz JM; Gailani D; Urbanus RT; de Groot PG; Gruber A; McCarty OJ
Arterioscler Thromb Vasc Biol; 2009 Oct; 29(10):1602-7. PubMed ID: 19661487
[TBL] [Abstract][Full Text] [Related]
12. The role of platelets in antiphospholipid syndrome.
Baroni G; Banzato A; Bison E; Denas G; Zoppellaro G; Pengo V
Platelets; 2017 Dec; 28(8):762-766. PubMed ID: 28267395
[TBL] [Abstract][Full Text] [Related]
13. Binding of beta 2-glycoprotein I to anionic phospholipids facilitates processing and presentation of a cryptic epitope that activates pathogenic autoreactive T cells.
Kuwana M; Matsuura E; Kobayashi K; Okazaki Y; Kaburaki J; Ikeda Y; Kawakami Y
Blood; 2005 Feb; 105(4):1552-7. PubMed ID: 15486070
[TBL] [Abstract][Full Text] [Related]
14. Exposure of anionic phospholipids upon platelet activation permits binding of beta 2 glycoprotein I and through it that of IgG antiphospholipid antibodies. Studies in platelets from patients with antiphospholipid syndrome and normal subjects.
Vázquez-Mellado J; Llorente L; Richaud-Patin Y; Alarcón-Segovia D
J Autoimmun; 1994 Jun; 7(3):335-48. PubMed ID: 7916907
[TBL] [Abstract][Full Text] [Related]
15. IgG reactivity to phospholipid-bound beta(2)-glycoprotein I is the main determinant of the fraction of lupus anticoagulant activity quenched by addition of hexagonal (II) phase phospholipid in patients with the clinical suspicion of antiphospholipid-antibody syndrome.
Safa O; Crippa L; Della Valle P; Sabbadini MG; Viganò D'Angelo S; D'Angelo A
Haematologica; 1999 Sep; 84(9):829-38. PubMed ID: 10477458
[TBL] [Abstract][Full Text] [Related]
16. Apolipoprotein E receptor 2 is involved in the thrombotic complications in a murine model of the antiphospholipid syndrome.
Romay-Penabad Z; Aguilar-Valenzuela R; Urbanus RT; Derksen RH; Pennings MT; Papalardo E; Shilagard T; Vargas G; Hwang Y; de Groot PG; Pierangeli SS
Blood; 2011 Jan; 117(4):1408-14. PubMed ID: 21119114
[TBL] [Abstract][Full Text] [Related]
17. Identification and characterization of LRP8 (apoER2) in human blood platelets.
Riddell DR; Vinogradov DV; Stannard AK; Chadwick N; Owen JS
J Lipid Res; 1999 Oct; 40(10):1925-30. PubMed ID: 10508213
[TBL] [Abstract][Full Text] [Related]
18. Extracellular cadherin repeat domains EC1 and EC5 of T-cadherin are essential for its ability to stimulate angiogenic behavior of endothelial cells.
Joshi MB; Kyriakakis E; Pfaff D; Rupp K; Philippova M; Erne P; Resink TJ
FASEB J; 2009 Nov; 23(11):4011-21. PubMed ID: 19638398
[TBL] [Abstract][Full Text] [Related]
19. F-spondin interaction with the apolipoprotein E receptor ApoEr2 affects processing of amyloid precursor protein.
Hoe HS; Wessner D; Beffert U; Becker AG; Matsuoka Y; Rebeck GW
Mol Cell Biol; 2005 Nov; 25(21):9259-68. PubMed ID: 16227578
[TBL] [Abstract][Full Text] [Related]
20. [Autoantibodies and thrombosis].
Koike T
Hokkaido Igaku Zasshi; 1997 Sep; 72(5):485-90. PubMed ID: 9363465
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
